Clearside Biomedical, Inc. (CLSDQ)
OTCMKTS · Delayed Price · Currency is USD
0.6500
+0.0219 (3.48%)
At close: Feb 5, 2026
Clearside Biomedical Employees
Clearside Biomedical had 32 employees as of December 31, 2024. The number of employees increased by 2 or 6.67% compared to the previous year.
Employees
32
Change (1Y)
2
Growth (1Y)
6.67%
Revenue / Employee
$104,031
Profits / Employee
-$812,375
Market Cap
3.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 32 | 2 | 6.67% |
| Dec 31, 2023 | 30 | -6 | -16.67% |
| Dec 31, 2022 | 36 | 2 | 5.88% |
| Dec 31, 2021 | 34 | 1 | 3.03% |
| Dec 31, 2020 | 33 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Orgenesis | 146 |
| Vaccinex | 27 |
| Mosaic ImmunoEngineering | 8 |
| AXIM Biotechnologies | 7 |
| Bioxytran | 3 |
Clearside Biomedical News
- 2 months ago - Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process - GlobeNewsWire
- 5 months ago - Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress - GlobeNewsWire
- 7 months ago - Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada - GlobeNewsWire
- 7 months ago - Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline - GlobeNewsWire
- 8 months ago - Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting - GlobeNewsWire
- 9 months ago - Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum - GlobeNewsWire
- 9 months ago - Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 months ago - Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting - GlobeNewsWire